Summary
- Current Price
- As of today, EW price is $92.03, up +2.57% on
- Current Price All-Time High
- EW price is currently -30.14% below its historical high of $131.73 set on
- Market Cap
- EW current market cap is $53B, up +15.04% over the past 365 days
- PE Ratio
- EW current PE ratio is 54.61
- Revenue
- EW current annual revenue is $6.07B, up +11.55% year-over-year
- Next Earnings
- The next earnings release for EW is on
Profile
| Metric | Value |
|---|---|
| Full Name | Edwards Lifesciences Corporation |
| Ticker | NYSE: EW |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | edwards.com |
| Employees | 15,800 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $92.03 | |
| Price, 1D Change | +2.57% | |
| Market Cap | $53B | |
| - | ||
| PE Ratio | 54.61 | |
| Beta | 0.55 | |
| Revenue | $6.07B | |
| Revenue, 1Y Change | +11.55% | |
| EPS | $1.81 | |
| EPS, 1Y Change | +24.00% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 3:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.81 | |
| EPS Estimate | $3.00 | N/A |
| EPS Est. Change | +65.68% | N/A |
| Revenue | $6.07B | |
| Revenue Estimate | $6.76B | N/A |
| Revenue Est. Change | +11.40% | N/A |
| Current Price | $92.03 | |
| Price Target | $101.50 | - |
| Price Tgt. Change | +10.29% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.55 | $1.46 | -42.67% | |
| $2.59 | $1.81 | -30.03% | |
| $3.00 | N/A | +65.68% | |
| $3.38 | N/A | +86.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.91B | $5.44B | -7.91% | |
| $6.03B | $6.07B | +0.54% | |
| $6.76B | N/A | +11.40% | |
| $7.43B | N/A | +22.44% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +17.46% | |
| Price, 3Y | +17.57% | |
| Market Cap, 1Y | +15.04% | |
| Market Cap, 3Y | +11.36% | |
| Revenue, 1Y | +11.55% | |
| Revenue, 3Y | +12.73% | |
| EPS, 1Y | +24.00% | |
| EPS, 3Y | -25.78% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $92.03 | |
| SMA 200 | $84.15 | |
| SMA 50 | $88.12 | |
| EMA 200 | $83.83 | |
| EMA 50 | $87.32 | |
| MACD | $0.51 | |
| Beta | 0.55 | |
| ATR | $2.48 | |
| 14-Day RSI | 64.01 | |
| 10-Day Volatility | 21.91% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $6.07B | |
| EPS | $1.81 | |
| Gross Profit | $4.74B | |
| Gross Margin | 78.13% | |
| Operating Income | $1.63B | |
| Operating Margin | 26.87% | |
| Net Income | $1.06B | |
| Net Margin | 17.40% | |
| EBITDA | $1.79B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.07 | |
| 3.72 | ||
| 3.09 | ||
| - | ||
| 8 | ||
| 12.19 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 54.61 | |
| 8.14 | ||
| 4.99 | ||
| 24.38 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $10.34B | |
| $4.23B | ||
| $13.70B | ||
| $6.74B | ||
| $3.36B | ||
| $1.81B | ||
| Total Debt | $705.40M | |
| $24.50M | ||
| $227.50M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $5.01B | ||
| $3.10B | ||
| $1.34B | ||
| $0.00 | ||
| $156.60M | ||
| $0.00 | ||
| $216.90M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.60B | ||
| -$946.60M | ||
| -$723.10M | ||
| Capex | $260.20M | |
| $1.34B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| Piper Sandler | → | |
| JP Morgan | → | |
| Truist Securities | → | |
| Mizuho | → | |
| RBC Capital | → | |
| Citigroup | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with EW
FAQ
- What is the ticker symbol for Edwards Lifesciences Corporation?
- The ticker symbol for Edwards Lifesciences Corporation is NYSE:EW
- Does Edwards Lifesciences Corporation pay dividends?
- No, Edwards Lifesciences Corporation does not pay dividends
- What sector is Edwards Lifesciences Corporation in?
- Edwards Lifesciences Corporation is in the Healthcare sector
- What industry is Edwards Lifesciences Corporation in?
- Edwards Lifesciences Corporation is in the Medical Devices industry
- What country is Edwards Lifesciences Corporation based in?
- Edwards Lifesciences Corporation is headquartered in United States
- When did Edwards Lifesciences Corporation go public?
- Edwards Lifesciences Corporation initial public offering (IPO) was on March 27, 2000
- Is Edwards Lifesciences Corporation in the S&P 500?
- Yes, Edwards Lifesciences Corporation is included in the S&P 500 index
- Is Edwards Lifesciences Corporation in the NASDAQ 100?
- No, Edwards Lifesciences Corporation is not included in the NASDAQ 100 index
- Is Edwards Lifesciences Corporation in the Dow Jones?
- No, Edwards Lifesciences Corporation is not included in the Dow Jones index
- When was Edwards Lifesciences Corporation last earnings report?
- Edwards Lifesciences Corporation's most recent earnings report was on July 23, 2026
- When does Edwards Lifesciences Corporation report earnings?
- The next expected earnings date for Edwards Lifesciences Corporation is October 29, 2026
Data Sources & References
- EW Official Website www.edwards.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1099800/000109980026000009/0001099800-26-000009-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- EW Profile on Yahoo Finance finance.yahoo.com/quote/EW
- EW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ew
